228 related articles for article (PubMed ID: 37314125)
1. Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure.
Smart CD; Fehrenbach DJ; Wassenaar JW; Agrawal V; Fortune NL; Dixon DD; Cottam MA; Hasty AH; Hemnes AR; Doran AC; Gupta DK; Madhur MS
Cardiovasc Res; 2023 Oct; 119(13):2312-2328. PubMed ID: 37314125
[TBL] [Abstract][Full Text] [Related]
2. CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction.
Zhang N; Ma Q; You Y; Xia X; Xie C; Huang Y; Wang Z; Ye F; Yu Z; Xie X
Int J Biol Sci; 2022; 18(3):1271-1287. PubMed ID: 35173552
[No Abstract] [Full Text] [Related]
3. Qiliqiangxin capsule improves cardiac remodeling in rats with DOCA-salt-induced diastolic dysfunction.
Hao JM; Sun P; Zeng Y; Zhang H; Zhang ZD; Chang LP; Hou YL
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7264-7275. PubMed ID: 37606135
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".
Mohammed SF; Ohtani T; Korinek J; Lam CS; Larsen K; Simari RD; Valencik ML; Burnett JC; Redfield MM
Circulation; 2010 Jul; 122(4):370-8. PubMed ID: 20625113
[TBL] [Abstract][Full Text] [Related]
5. A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
Schwarzl M; Hamdani N; Seiler S; Alogna A; Manninger M; Reilly S; Zirngast B; Kirsch A; Steendijk P; Verderber J; Zweiker D; Eller P; Höfler G; Schauer S; Eller K; Maechler H; Pieske BM; Linke WA; Casadei B; Post H
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1407-18. PubMed ID: 26342070
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting the MAPK pathway improves heart failure with preserved ejection fraction induced by salt-sensitive hypertension.
Li S; Shi Y; Yuan S; Ruan J; Pan H; Ma M; Huang G; Ji Q; Zhong Y; Jiang T
Biomed Pharmacother; 2024 Jan; 170():115987. PubMed ID: 38056241
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension.
Saito T; Mizobuchi M; Kato T; Ogata H; Koiwa F; Honda H
Lab Invest; 2023 Jan; 103(1):100003. PubMed ID: 36748187
[TBL] [Abstract][Full Text] [Related]
8. Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Wu H; Tang LX; Wang XM; Li LP; Chen XK; He YJ; Yang DZ; Shi Y; Shou JL; Zhang ZS; Wang L; Lu BJ; An SM; Zeng CY; Wang WE
Acta Pharmacol Sin; 2023 Jun; 44(6):1149-1160. PubMed ID: 36473990
[TBL] [Abstract][Full Text] [Related]
9. High-salt diet downregulates TREM2 expression and blunts efferocytosis of macrophages after acute ischemic stroke.
Hu M; Lin Y; Men X; Wang S; Sun X; Zhu Q; Lu D; Liu S; Zhang B; Cai W; Lu Z
J Neuroinflammation; 2021 Apr; 18(1):90. PubMed ID: 33845849
[TBL] [Abstract][Full Text] [Related]
10. Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype.
Li Y; Kubo H; Yu D; Yang Y; Johnson JP; Eaton DM; Berretta RM; Foster M; McKinsey TA; Yu J; Elrod JW; Chen X; Houser SR
Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H443-H460. PubMed ID: 36763506
[TBL] [Abstract][Full Text] [Related]
11. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
12. Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction.
Brandt MM; Nguyen ITN; Krebber MM; van de Wouw J; Mokry M; Cramer MJ; Duncker DJ; Verhaar MC; Joles JA; Cheng C
J Cell Mol Med; 2019 Oct; 23(10):6666-6678. PubMed ID: 31368189
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
15. Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low-Density Lipoprotein Receptor Expression.
Williams M; Capcha JMC; Irion CI; Seo G; Lambert G; Kamiar A; Yousefi K; Kanashiro-Takeuchi R; Takeuchi L; Saad AG; Mendez A; Webster KA; Goldberger JJ; Hare JM; Shehadeh LA
J Am Heart Assoc; 2022 Sep; 11(17):e027216. PubMed ID: 36056728
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.
Jennings BL; Estes AM; Anderson LJ; Fang XR; Yaghini FA; Fan Z; Gonzalez FJ; Campbell WB; Malik KU
Hypertension; 2012 Dec; 60(6):1510-6. PubMed ID: 23108654
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction.
Kanashiro-Takeuchi RM; Takeuchi LM; Dulce RA; Kazmierczak K; Balkan W; Cai R; Sha W; Schally AV; Hare JM
Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H739-H750. PubMed ID: 36897749
[TBL] [Abstract][Full Text] [Related]
18. Genetic ablation and pharmacological inhibition of immunosubunit β5i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice.
Cao HJ; Fang J; Zhang YL; Zou LX; Han X; Yang J; Yan X; Li PB; Wang HX; Guo SB; Li HH
J Mol Cell Cardiol; 2019 Dec; 137():34-45. PubMed ID: 31629736
[TBL] [Abstract][Full Text] [Related]
19. JMJD3 ablation in myeloid cells confers renoprotection in mice with DOCA/salt-induced hypertension.
Gao Y; Yu W; Song J; Nie J; Cui Z; Wen S; Liu B; Liang H
Hypertens Res; 2023 Aug; 46(8):1934-1948. PubMed ID: 37248323
[TBL] [Abstract][Full Text] [Related]
20. Exercise training reverses cardiac aging phenotypes associated with heart failure with preserved ejection fraction in male mice.
Roh JD; Houstis N; Yu A; Chang B; Yeri A; Li H; Hobson R; Lerchenmüller C; Vujic A; Chaudhari V; Damilano F; Platt C; Zlotoff D; Lee RT; Shah R; Jerosch-Herold M; Rosenzweig A
Aging Cell; 2020 Jun; 19(6):e13159. PubMed ID: 32441410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
